Navigating Change Management in Big Pharma: FC365 Forecasting Platform from J+D

Change management within big pharmaceutical companies, particularly when updating or changing forecasting methods, is a complex undertaking rife with challenges. The industry, driven by rigorous regulatory requirements and evolving market dynamics, often faces resistance to adopting new technologies or processes. However, the introduction of the FC365 forecasting platform from J+D Forecasting is changing the game, addressing these hurdles while allowing teams to continue using familiar tools like Microsoft Excel, Teams and SharePoint.

Forecasting Transformation: Overcoming Change Management Challenges in Pharma

Resistance to
Change

In a sector where precision is paramount, employees are often hesitant to switch from the tools and processes they are comfortable with. Implementing new solutions may face resistance, as team members fear errors, delays, or complications.

Learning
Curve

Learning new software or processes can be time-consuming and may disrupt daily operations. Extensive training sessions and referencing user manuals can slow down the transition, leading to a decrease in productivity.

Integration
Issues

Pharmaceutical companies often have established forecasting models and data systems. Integrating a new platform can be a challenge, with the potential for data inconsistencies and loss during the transition.

Regulatory
Compliance

Strict regulatory requirements necessitate a seamless transition without compromising data integrity. Any disruption can lead to compliance issues, which are costly and detrimental to the reputation of pharmaceutical companies.

FC365 Forecasting Platform: Bridging the Gap

FC365 offers an innovative solution to these change management challenges by allowing pharmaceutical companies to continue using their preferred tools, as it keeps Microsoft Excel at its core and can be accessed via Teams or as a standalone application. Here’s how FC365 is addressing the challenges change can bring:

1. Familiarity and Reduced Learning Curve

By seamlessly integrating with the Microsoft suite of tools, FC365 eliminates the need for teams to learn an entirely new platform. Users can get to work immediately, without the disruptions associated with learning a new system.

2. User-Friendly Interface

FC365’s user-friendly interface streamlines forecasting processes, reducing the reliance on extensive training sessions and user manuals. It empowers employees to adapt quickly, maintaining productivity levels. The need for vendor support is minimal.

3. Data Integration

FC365 enables smooth integration with existing forecasting models and data systems. This eliminates the risk of data inconsistencies and loss, ensuring continuity in operations.

4. Regulatory Compliance

Users have the option to integrate their own forecasting models into FC365 or switch to dedicated forecasting software if required. This flexibility allows companies to tailor the platform to their unique needs, optimizing functionality as required.

5. Flexibility to Improve Functionality

Users have the option to integrate their own forecasting models into FC365 or switch to dedicated forecasting software if required. This flexibility allows companies to tailor the platform to their unique needs, optimizing functionality as required.

Conclusion:

By allowing users to stay with their familiar tools, FC365 is offering an innovative approach to minimize resistance, reduce the learning curve, facilitate data integration, and ensure regulatory compliance. With FC365, pharmaceutical companies can confidently embrace change while maintaining their commitment to precision and excellence.

Want to learn more about FC365 for your forecasting processes? Book a call with one of our expert team below:

Speak with an expert.

more insights

Our Pharmaceutical Forecasting Predictions for 2024

As the pharmaceutical industry contends with growing financial pressures, we examine its strategic outlook for 2024. How does the sector intend to align with projected commercial objectives while continuing to meet patient needs and what are the implications for forecasting teams?

Read more >